About Index Trending news
Lists
Pricing
NuCana BioMed

NuCana BioMed

NuCana BioMed

A clinical stage biopharmaceutical company transforming anti-cancer agents into better and safer medicines that overcome key resistance mechanisms

Elsewhere

Alexa global traffic share

Twitter followers

28 Sep 2017
$100,000,000
Post-IPO equity
10 Apr 2014
$57,000,000
Venture capital (Series B)
29 Nov 2011
$10,529,448
Venture capital (Series A)